CDKN2A and glioblastoma: To better characterize the effects of CDKN2A homozygous deletion on survival, we performed subgroup analysis of IDHwt glioblastoma patients with CDKN2A copy deletions (CDKN2Adel) and with intact CDKN2A genes (CDKN2Aint).